<?xml version="1.0" encoding="UTF-8"?>
<supplementary-material content-type="local-data" id="sct312331-supitem-0001">
 <caption>
  <p>
   <bold>Figure S1. Changes of serum levels of IL‐1β, IL‐6, IL‐8, IL‐10 and TNF‐α from baseline at 24 hours of hUCB‐MSC infusion (n = 9).</bold> TNF‐α, tumor necrosis factor alpha; hUCB‐MSCs, human umbilical cord blood‐derived mesenchymal stem cell.
  </p>
  <p>
   <bold>Figure S2. Subgroup analysis of changes of serum levels of IL‐1β, IL‐6, IL‐8, IL‐10 and TNF‐α from baseline at 24 hours of hUCB‐MSC infusion in the (A) 2.5 x 10</bold>
   <sup>
    <bold>7</bold>
   </sup>
   <bold>group (n = 3), (B) 5 x 10</bold>
   <sup>
    <bold>7</bold>
   </sup>
   <bold>group (n = 3), and (C) 1 x 10</bold>
   <sup>
    <bold>8</bold>
   </sup>
   <bold>cells group (n = 3).</bold> TNF‐α, tumor necrosis factor alpha; hUCB‐MSCs, human umbilical cord blood‐derived mesenchymal stem cell. *
   <italic>p</italic> &lt; .05, before versus after treatment (Wilcoxon signed rank test).
  </p>
 </caption>
 <media xlink:href="SCT3-7-636-s001.docx" xmlns:xlink="http://www.w3.org/1999/xlink">
  <caption>
   <p>Click here for additional data file.</p>
  </caption>
 </media>
</supplementary-material>
